Home
About Us
News & Events
Equality & Human Rights
Accessibility
Contact
(Requires Javascript)
Search Site
Advanced Search…
Services
Advice & Guidance
Wellbeing
Your Involvement
Members
Professionals
Jobs
You are here:
Home
›
About Us
›
Policies and Procedures
›
M - O
›
Medicine Codes/SABP/EXECUTIVE BOARD/0017
›
Medicines Guideline Hypnotic Medication SABP/EXECUTIVE BOARD/0017
›
Medicines Guideline Hypnotic Medication SABP/EXECUTIVE BOARD/0017/Guideline 03
Navigation
About Us
Vision and Values
Board of Directors
Partnership People
Strategies & Reports
Public Board meetings
Financial Reports
Policies and Procedures
A - C
D - F
G - I
J - L
M - O
Medicine Codes/SABP/EXECUTIVE BOARD/0017
Medicines Procedure Anticoagulants/SABP/EXECUTIVE BOARD/0017
Medicines Procedure:Formulary and Prescribing Guildlines SABP/EXECUTIVE BOARD/0017
Medicines Procedure FP10 Prescriptions SABP/EXECUTIVE BOARD/0017
Medicines Guideline High Dose Antipsychotics SABP/EXECUTIVE BOARD/0017
Medicines Guideline Hypnotic Medication SABP/EXECUTIVE BOARD/0017
Medicines Guideline Hypnotic Medication SABP/EXECUTIVE BOARD/0017/Guideline 03
P - R
S - U
V - Z
Equality & Human Rights
Freedom of Information
Single Sex Accommodation
Service Developments
Research & Development
STARS Awards 2012
Info
Medicines Guideline Hypnotic Medication SABP/EXECUTIVE BOARD/0017/Guideline 03
— PDF document, 110 kB (113513 bytes)